Literature DB >> 9754453

Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats.

A Dahchour1, P De Witte, N Bolo, J F Nédélec, M Muzet, P Durbin, J P Macher.   

Abstract

One of the known behavioral actions of acamprosate is to decrease hypermotility during alcohol withdrawal. However, the mechanism of this effect remains unclear. In this study, the concentrations of excitatory and inhibitory amino acids were assayed by the microdialysis technique with OPA/BME precolumn derivatization and electrochemical detection in the nucleus accumbens of male Wistar rats which were either alcoholized by ethanol inhalation or simultaneously alcoholized and treated orally by acamprosate (400 mg/kg/day) for 4 weeks. Without treatment, extracellular glutamate increased during the withdrawal phase, while other amino acids tested (aspartate, arginine, taurine, alanine and GABA) remained stable. In contrast, the alcoholized rats treated with acamprosate failed to present the increase in glutamate during ethanol withdrawal, while other amino acids tested also remained stable. The observed glutamate increase could be responsible for the hyperexcitability observed during episodes of ethanol withdrawal. These results suggest that acamprosate is able to reduce the ethanol withdrawal syndrome by reducing the concentration of glutamate in the nucleus accumbens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754453     DOI: 10.1016/s0925-4927(98)00016-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  44 in total

Review 1.  Microdialysis as a tool in local pharmacodynamics.

Authors:  Yanjun Li; Joanna Peris; Li Zhong; Hartmut Derendorf
Journal:  AAPS J       Date:  2006-04-07       Impact factor: 4.009

Review 2.  Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.

Authors:  Philippe De Witte; John Littleton; Philippe Parot; George Koob
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Homers regulate drug-induced neuroplasticity: implications for addiction.

Authors:  Karen K Szumlinski; Alexis W Ary; Kevin D Lominac
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

4.  Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.

Authors:  David J Hinton; Moonnoh R Lee; Taylor L Jacobson; Prasanna K Mishra; Mark A Frye; David A Mrazek; Slobodan I Macura; Doo-Sup Choi
Journal:  Neuropharmacology       Date:  2012-06       Impact factor: 5.250

Review 5.  Addiction: the clinical interface.

Authors:  D Nutt; A Lingford-Hughes
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

6.  Role of altered structure and function of NMDA receptors in development of alcohol dependence.

Authors:  József Nagy; Sándor Kolok; András Boros; Péter Dezso
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

7.  Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2.

Authors:  Osama A Abulseoud; Ulas M Camsari; Christina L Ruby; Aimen Kasasbeh; Sun Choi; Doo-Sup Choi
Journal:  Neuropsychopharmacology       Date:  2014-01-23       Impact factor: 7.853

Review 8.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

9.  Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats.

Authors:  M Scott Bowers; Billy T Chen; Jonathan K Chou; Megan P H Osborne; Justin T Gass; Ronald E See; Antonello Bonci; Patricia H Janak; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2007-09-02       Impact factor: 4.530

Review 10.  Peter Riederer "70th birthday" neurobiological foundations of modern addiction treatment.

Authors:  Christian Jacob
Journal:  J Neural Transm (Vienna)       Date:  2012-08-19       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.